Scientific Industries, Inc.
22.69%
2,965,026
87802
808757108
Apr 17, 2025
Apr 22, 2025, 04:40 PM
Reporting Persons (3)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Bleichroeder LP | Investment Adviser | 22.69% | 2,965,026 | 2,965,026 | 0 |
| Bleichroeder Holdings LLC | Holding Company | 22.69% | 2,965,026 | 2,965,026 | 0 |
| Andrew Gundlach | Individual | 22.69% | 2,965,026 | 2,965,026 | 0 |
Disclosure Items (3)
Item 3 is hereby amended to include the following: On April 18, 2025, the Issuer entered into a Securities Purchase Agreement (the "Purchase Agreement") with, among other persons, funds managed by the Reporting Persons providing for the issuance and sale, for an aggregate purchase price of $250,000, of 250,000 Shares and Warrants to purchase 250,000 Shares at an exercise price of $1.00 per Share.
Item 5 is hereby amended to include the following: As of the date of this Schedule 13D, the Reporting Persons beneficially own 2,965,026 Shares, representing 22.69% of the outstanding Shares (including Shares that will be issuable upon the exercise of the Warrants). The percentages used herein are based upon (i) the 10,503,599 Shares reported as outstanding as of March 27, 2025 by the Issuer in its Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2025, (ii) the 1,050,000 Shares issued on April 18, 2025 as reported by the Issuer in its 8-K filed with the Securities and Exchange Commission on April 22, 2025 and (iii) the 1,511,675 Shares issuable upon the exercise of the Warrants.
The Reporting Persons have sole voting and dispositive power over 2,965,026 Shares.
Except as set forth in Item 3, the Reporting Persons have not affected any transaction in the Shares during the past sixty days.
No person other than the Reporting Persons and the managed accounts or funds which hold the Shares is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
Not applicable.
Exhibit 99.1: Introductory Statement